News

Eli Lily warns of temporary insulin shortages due to manufacturing issues

Eli Lilly has issued a cautionary notice about the limited availability of two of its insulin brands, stating that they will be temporarily out of stock until later this month. 

The affected products are the 10-milliliter vials of Humalog and Insulin Lispro Injection. However, Lilly assured that it is actively producing these products and once they become available they will dispatch them as quickly as possible. 

In a statement, the company said: “We recognize that any supply challenge may cause a disruption in people’s treatment regimens, and we are moving with urgency to address it. 

Anyone experiencing difficulty in getting their prescription filled should contact their healthcare provider to discuss switching to the same insulin in a prefilled pen or other insulin treatment options. Additionally, patients may check other pharmacies in their insurance network for available supply. Patients who need insulin immediately and cannot access their healthcare provider for an alternative treatment option should seek emergency care.

In the meantime, all other Lilly insulin products – including Humalog and Insulin Lispro Injection in prefilled pens (KwikPen) – are currently available in the U.S. We are in ongoing contact with the FDA (Food and Drug Administration).”

Insulin has been around for over 100 years, but recently there has been a surge in prices. Companies have been under pressure to reduce prices in the US, as the drug is not expensive to manufacture and many patients need it for regular treatment. 

It has been reported by medical researchers that the cost of insulin has risen by 11% every year between 2001 and 2018, and the total costs were approaching $6,000 a month. 

Eli Lily recently announced that it would cut prices to $35 for patients with medical insurance. According to the company, this is a reduction of 70%. Additionally, the company said that nonbranded insulin would be reduced to $25 from $82.41, making it the cheapest insulin product currently available on the market. 

Linda Conrad

Recent Posts

Chinstrap Penguins Decline Sharply on Remote Antarctic Island

A remote volcanic island near Antarctica has lost its status as home to the world's…

7 days ago

Could Laughing More Actually Improve Your Health?

  Laughter is usually treated as a response to something funny, but researchers are finding…

2 weeks ago

Iran President Pezeshkian Heads to UN General Assembly

  Iranian President Masoud Pezeshkian is preparing to travel to New York for the United…

2 weeks ago

Apple Unveils First Foldable iPhone Under CEO John Ternus

Apple has entered the foldable smartphone market with the launch of the iPhone Duo, marking…

3 weeks ago

Smoking and Heart Health Risks Many People Still Miss

  Most people who smoke understand that cigarettes can cause lung cancer, but far fewer…

3 weeks ago

COVID-19 Vaccine Delays Leave Millions of US Children Waiting

  Updated COVID-19 vaccines are facing delays for children across the United States as a…

4 weeks ago